These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7056584)

  • 21. Acne-like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model: correlation with ability to stimulate the reticuloendothelial system.
    De Young LM; Spires DA; Ballaron SJ; Cummins CS; Young JM; Allison AC
    J Invest Dermatol; 1985 Sep; 85(3):255-8. PubMed ID: 3161957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.
    Shimizu Y; Margenthaler JA; Landeros K; Otomo N; Doherty G; Flye MW
    Hepatology; 2002 Apr; 35(4):805-14. PubMed ID: 11915026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Propionibacterium acnes treatment on the course of Mycobacterium leprae infection in mice.
    Krahenbuhl JL; Humphres RC; Henika PC
    Infect Immun; 1982 Jul; 37(1):183-8. PubMed ID: 7049949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of CD14 in LPS-induced liver injury and lethality in mice pretreated with Propionibacterium acnes.
    Shuto Y; Kataoka M; Higuchi Y; Matsuura K; Hijiya N; Yamamoto S
    Immunol Lett; 2004 Jun; 94(1-2):47-55. PubMed ID: 15234535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
    Mory F; Fougnot S; Rabaud C; Schuhmacher H; Lozniewski A
    J Antimicrob Chemother; 2005 Feb; 55(2):265-8. PubMed ID: 15590714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased sensitivity of Corynebacterium parvum-treated mice to toxic effects of indomethacin and lipopolysaccharide.
    Hart DA
    Infect Immun; 1985 Feb; 47(2):408-14. PubMed ID: 3881348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of Propionibacterium acnes strains on semisynthetic medium; antigenic polysaccharide production.
    Cabrera M; Gil I; Rodriguez D
    Zentralbl Mikrobiol; 1983; 138(5):391-5. PubMed ID: 6649955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of group A streptococcal variants treated with mitomycin C. Appearance of cell wall galactosamine and uridine diphosphate-N-acetylglucosamine-4-epimerase activity.
    Hirano T; Ito T; Tomura T; Yoshioka M
    Jpn J Microbiol; 1973 Jan; 17(1):53-62. PubMed ID: 4573116
    [No Abstract]   [Full Text] [Related]  

  • 29. Observations on the nature of the determinants in anaerobic coryneforms which produce splenomegaly.
    Cummins CS; Stimpson SA; Tuttle RL; Weck CJ
    J Reticuloendothel Soc; 1981 Jan; 29(1):1-13. PubMed ID: 6259348
    [No Abstract]   [Full Text] [Related]  

  • 30. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.
    Webster GF; Leyden JJ; McGinley KJ; McArthur WP
    Antimicrob Agents Chemother; 1982 May; 21(5):770-2. PubMed ID: 7049078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of temperature on the sensitivity of staphylococcus aureus to different antibiotics.
    Waterman NG; Danziger FS; Abrams BL
    Surg Gynecol Obstet; 1967 Feb; 124(2):262-8. PubMed ID: 5334492
    [No Abstract]   [Full Text] [Related]  

  • 33. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro evaluation of marine derived fungi against Cutibacterium acnes.
    Agrawal S; Adholeya A; Barrow CJ; Deshmukh SK
    Anaerobe; 2018 Feb; 49():5-13. PubMed ID: 29100929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical properties of the principle in C. parvum that produces splenomegaly in mice.
    Riveros-Moreno V; Niblock A
    Immunology; 1979 Mar; 36(3):495-9. PubMed ID: 220183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions.
    Millman I; Scott AW; Halbherr T
    Cancer Res; 1977 Nov; 37(11):4150-5. PubMed ID: 409491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic control of Propionibacterium acnes-induced protection of mice against Babesia microti.
    Wood PR; Clark IA
    Infect Immun; 1982 Jan; 35(1):52-7. PubMed ID: 7054129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic interactions between prophages induce lysis in Propionibacterium acnes.
    L Brown T; Tucci J; Dyson ZA; Lock P; Adda CG; Petrovski S
    Res Microbiol; 2017; 168(2):103-112. PubMed ID: 27639668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin.
    Webster GF; McGinley KJ; Leyden JJ
    Br J Dermatol; 1981 Apr; 104(4):453-7. PubMed ID: 6786318
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of Pulmonary Granuloma Formation by Propionibacterium acnes Is Regulated by MyD88 and Nox2.
    Werner JL; Escolero SG; Hewlett JT; Mak TN; Williams BP; Eishi Y; Núñez G
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):121-130. PubMed ID: 27607191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.